NEW YORK, Jan. 19 /PRNewswire-FirstCall/ -- Pfizer Animal Health, a division of Pfizer Inc (NYSE:PFE) today announced the completion of its acquisition of Embrex, Inc. (NASDAQ:EMBX), an...
RESEARCH TRIANGLE PARK, N.C., Dec. 12 /PRNewswire-FirstCall/ -- Embrex(R), Inc., The In Ovo Company(R), (NASDAQ:EMBX) announced that a special meeting of its shareholders will be held on January...
NEW YORK and RESEARCH TRIANGLE PARK, N.C., Nov. 15 /PRNewswire-FirstCall/ -- Pfizer Animal Health, a division of Pfizer Inc (NYSE:PFE) has agreed to acquire Embrex, Inc. (NASDAQ:EMBX), an...
RESEARCH TRIANGLE PARK, N.C., Nov. 6 /PRNewswire-FirstCall/ -- Embrex(R), Inc., The In Ovo Company(R), (NASDAQ:EMBX) announces financial results for the third quarter ended September 30, 2006...
RESEARCH TRIANGLE PARK, N.C., Oct. 20 /PRNewswire-FirstCall/ -- Embrex(R), Inc., The In Ovo Company(R), (NASDAQ:EMBX) announced Embrex management intends to file its Third Quarter 2006 Form 10-Q...
RESEARCH TRIANGLE PARK, N.C., Aug. 7 /PRNewswire/ -- Embrex(R), Inc., The In Ovo Company(R), (NASDAQ:EMBX) announces financial results for the second quarter ended June 30, 2006. Highlights...
RESEARCH TRIANGLE PARK, N.C., Aug. 1 /PRNewswire-FirstCall/ -- Embrex, Inc., The In Ovo Company(R), (NASDAQ:EMBX) has recently delivered to Shenzhen Neptunus Interlong Bio-technique Co. Ltd...
RESEARCH TRIANGLE PARK, N.C., July 17 /PRNewswire-FirstCall/ -- Embrex(R), Inc., The In Ovo Company(R), (NASDAQ:EMBX) announced Embrex management intends to file its Second Quarter 2006 Form...
RESEARCH TRIANGLE PARK, N.C., May 8 /PRNewswire-FirstCall/ -- Embrex(R), Inc., The In Ovo Company(R), (NASDAQ:EMBX) announces financial results for the first-quarter ended March 31, 2006...
Embrex(R), Inc., The In Ovo Company(R), (Nasdaq:EMBX) announced Embrex management intends to file its First Quarter 2006 Form 10-Q and issue its financial press release on Monday, May 8, 2006...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales